To determine steady-state plasma concentrations and the pharmacokinetic profile of the essential components of synthetic conjugated estrogens , B ( SCE-B ) , particularly total estrone and delta8,9-dehydroestrone ( DHE ) , after oral administration of a modified-released tablet .
